Genetically modified organisms, also known as GMOs, have been a hot topic of conversation among researchers, producers, ...

We have written about the promise of gene therapy to correct genetic disease many times. An exciting development happened ...

The grantmaking organization Open Philanthropy has awarded funding for a University of California San Diego technology ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

CRISPR technology could one day create “designer babies, ” raising major ethical and social inequality concerns.

In a world first, a bespoke gene-editing therapy benefited one child. Now researchers plan to launch a clinical trial of the approach ...

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

Gene editing techniques, including CRISPR, prime editing, and nucleases, allow scientists to tackle genetic diseases, cancer, ...

Researchers have identified molecular mechanisms behind age-related memory decline — and shown they can be reversed.

Two gene-editing companies are advancing therapies, with one generating commercial sales and both approaching major regulatory milestones. An AI drug discovery company is approaching multiple trial ...